Industry News

• SurModics licenses ophthalmology technology to ForSight Labs  SurModics announced today that it has entered into an agreement with ForSight Labs to license certain non-core ophthalmology technology. The technology licensed in this agreement does not include the Company's I-vation(TM) drug delivery technology.
  SurModics, Inc. March 17, 2010  
• Medtronic completes Pre-Market Approval submission to FDA for Arctic Front(R)  Medtronic announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug Administration (FDA) approval for the Medtronic Arctic Front(R) Cardiac CryoAblation Catheter System.
  Medtronic, Inc. March 17, 2010  
• Next-generation pacing system for use in MRI machines now commercially available  Medtronic announced the commercial availability of the Advisa DR MRI(TM) SureScan(TM) pacemaker in selected European geographies.
  Medtronic, Inc. March 17, 2010  
• U.S. Food And Drug Administration accepts New Drug Application  Bristol-Myers Squibb and AstraZeneca announced that the FDA has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA(TM) (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets.
  Bristol-Myers Squibb Company March 17, 2010  
• Medtronic receives FDA approval for integrated system for diabetes management  Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm(R) REAL-Time Revel(TM) System, the next generation of the industry's only integrated diabetes management system.
  Medtronic, Inc. March 17, 2010  
• Study shows Prevenar 13* is immunogenic in young children previously vaccinated  According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13* was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar* (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed).
  Pfizer Inc. March 17, 2010  
• Boston Scientific completes enrollment in PLATINUM trials  Boston Scientific announced completion of patient enrollment in the Small Vessel and Long Lesion trials of its PLATINUM clinical program that are designed to compare the platinum chromium PROMUS® Element Everolimus-Eluting Stent System to matched historical control groups of patients.
  Boston Scientific Corporation March 16, 2010  
• New PLATO sub-analysis of CABG patients presented at ACC  AstraZeneca announced results of a new analysis of the PLATO study which showed there were fewer deaths in patients with acute coronary syndromes who took the investigational oral antiplatelet BRILINTA within seven days prior to having heart bypass surgery compared to those who took clopidogrel.
  AstraZeneca March 16, 2010  
• Additional $162 million in Recovery Act investment to advance health IT  U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced awards to help states facilitate health information exchange and advance health information technology (health IT).
  Dept. of Health & Human Services March 15, 2010  
• Pentair names new general counsel  Pentair announced that Angela Lageson has been named senior vice president, general counsel and secretary succeeding Louis Ainsworth who announced his plan to retire in mid 2010.
  Pentair, Inc. March 15, 2010  

   (next 10 articles)